Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
161. Metz LM, Patten SB, Archibald CJ, Bakker JI, Harris CJ, Patry DG, Bell RB, Yeung M, Murphy WF, Stoian<br />
CA, Billesberger K, Tillotson L, Peters S, McGowan D (2004) The effect <strong>of</strong> immunomodulatory treat-<br />
ment on multiple sclerosis fatigue. J Neurol Neurosurg Psychiat 75:1045-1047<br />
162. Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, Terpstra S, Stewart R (1997)<br />
Effect <strong>of</strong> intrathecal bacl<strong>of</strong>en delivered by an implanted programmable pump on health related<br />
quality <strong>of</strong> life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63:204-209<br />
163. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG,<br />
Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA (1999) Practice parameter:<br />
the care <strong>of</strong> the patient with amyotrophic lateral sclerosis (an evidence-based review): report <strong>of</strong><br />
the Quality Standards Subcommittee <strong>of</strong> the American Academy <strong>of</strong> Neurology: ALS Practice<br />
Parameters Task Force. Neurology 52:1311-1323<br />
164. Miller Sorensen P. Dysarthria (2000) In: Burks JS, Johnson KP. <strong>Multiple</strong> sclerosis. Diagnosis, medical<br />
management, and rehabilitation. New York: Demos; 388-391<br />
165. Mohler JL, Cowen DL, Flanigan RC (1987) Suppression and treatment <strong>of</strong> urinary tract infection in<br />
patients with an intermittently catheterized neurogenic bladder. J Urol 138:336-340<br />
166. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L (2001) Comparative outcomes for<br />
individual cognitive-behaviour therapy, supportive-expressive group psychotherapy, and sertraline<br />
for the treatment <strong>of</strong> depression in multiple sclerosis. J Consult Clin Psychol 69:942-949<br />
167. Mohr DC, Burke H, Beckner V, Merluzzi N (2005) A preliminary report on a skills-based telephoneadministered<br />
peer support programme for patients with multiple sclerosis. Mult Scler 11:222-226<br />
168. Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin BH, Montgomerie J, Vickrey BG (2002) Antimicrobial<br />
prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys<br />
Med Rehabil 83:129-138<br />
169. Mostert S, Kesselring J (2002) Effects <strong>of</strong> a short-term exercise training program on aerobic fitness,<br />
fatigue, health perception and activity level <strong>of</strong> subjects with multiple sclerosis. Mult Scler 8:161-<br />
168<br />
170. Mostert S, Kesselring J (2005) Effect <strong>of</strong> pulsed magnetic field therapy on the level <strong>of</strong> fatigue in<br />
patients with <strong>MS</strong> – a randomised controlled trial. Mult Scler 11:302-305<br />
171. Mueller ME, Gruenthal M, Olson WL, Olson WH (1997) Gabapentin for relief <strong>of</strong> upper motor<br />
neuron symptoms in multiple sclerosis. Arch Phys Med Rehabil 78:521-524<br />
172. <strong>Multiple</strong> <strong>Sclerosis</strong> – <strong>Treatment</strong> Consensus Group (<strong>MS</strong>TCG) (2004) Escalating immunotherapy <strong>of</strong><br />
multiple sclerosis. New aspects and practical application. J Neurol 251:1329-1339<br />
173. <strong>Multiple</strong> Sklerose – Therapie Konsensus Gruppe (<strong>MS</strong>TKG) (2004) <strong>Symptomatic</strong> therapy <strong>of</strong> multiple<br />
sclerosis. Nervenarzt 75 Suppl 1:S2-S39<br />
174. <strong>Multiple</strong> Sklerose – Therapy Konsensus Gruppe (<strong>MS</strong>TKG) (1999) Immunomodulating escalating<br />
therapy <strong>of</strong> multiple sclerosis. Nervenarzt 70:371-386<br />
E<strong>MS</strong>P, <strong>Symptomatic</strong> <strong>Treatment</strong> <strong>of</strong> <strong>Multiple</strong> <strong>Sclerosis</strong>, December 2006 - revised in April 2008 52
Change language